🧬 Mebendazole & Cancer — The Science Behind the Mechanisms Mebendazole is often dismissed as “just” an antiparasitic drug. But when you look at the research, a very different picture appears. Mebendazole belongs to the benzimidazole family — compounds widely studied for their effects on cell division and tumor biology. And importantly, Johns Hopkins University filed patents covering the use of mebendazole in cancer, including glioblastoma — which tells you this drug has been taken seriously at

Ivermectin and Mebendazole for Stage 4 Cancer: 257 Case Reports Compilation (October 2025 Edition)